The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Medimark takeover on Friday (30th Aug). Might give a sense of a larger company. But guess some sorting out following final completion date.
Hi - I’m never right on shares - so unpredictable! But I have some moderate optimism that the delay on final report may be due to certain significant events about to occur, eg new trials or new partners. Been so in the past. Of course, financials now more complicated with the takeover deal - so maybe just new, part-time CFO having to learn all about it.
Looks like results next wee or week after then. Quite excited at those ebitda prospects. Trek
Well hi EC, nice to see someone else posting here. Sometimes ones research can lead to lonely places. Trek, if you like loneliness check out TXP and DCTA! Loneliness has its rewards!
I think we could see 3p again soon. Holding up well in this market. Nice one to trade a few this as if you miss any opportunities it’s still a good long term hold imo. Trek
News in Aug punt money moving in. They could after 12 months now of revenue from MSL and if they have higher penetration in US come out ebitda neutral in finals. Loss was £450k last update but so many costs were included then. Could be anything from £100k loss to almost positive and with cash still on books market should like the story. If they announce a partner as well then that will be icing on cake and massive rerate. Trouble with aim though it’s a nightmare to work out as the whole market just could be awaiting new partner deal when for Trek I think it’s the ebit number that is key next. We’ll see but imo even if it disappoints the sales are coming through so you just have to wait a bit longer. Trek, good bet this one
News expected soon regarding the Byotrol surface cleanser trial in the USA at around 250 "Target" supermarkets.
Incidently I was in "Pets at home" yesterday here in the UK and there are loads of Byotrol badged products. They have 370 stores I see.
Interesting times.
All IMHO.